Candid Therapeutics Raises $370M to Advance T-Cell Engager Drugs for Autoimmune Diseases
Candid Therapeutics, a San Diego-based biotechnology company, has secured $370 million in funding to accelerate the development of its innovative ...
Candid Therapeutics, a San Diego-based biotechnology company, has secured $370 million in funding to accelerate the development of its innovative ...
Enveda Biosciences, a biotechnology company leveraging artificial intelligence to develop new medicines, has secured $55 million in funding to enhance ...
Profluent, an AI-driven protein design company, has raised an additional $35 million funding round, bringing its total raised capital to ...
California-based biotech firm Unnatural Products has successfully raised $32 million in a Series A funding round led by Merck Global ...
Philadelphia-based biotech firm Vivodyne has secured $38 million in seed funding led by Khosla Ventures to pioneer drug discovery with ...
Triplebar, a startup working in food and biopharmaceuticals, has recently secured a substantial $20 million in funding to expand its ...
Triveni Bio, a biotech company headquartered in Waltham, MA, has secured $92 million in Series A funding to propel their ...
In a leap toward transforming cancer screening and detection globally, Cambridge-based biotechnology firm Harbinger Health, specializing in cancer screening and ...
AeroSafe Global, a biopharmaceutical cold chain solutions provider, has successfully concluded a $43 million funding round. Spearheaded by NewSpring through ...
Bellevue-based longevity and preventative healthcare company Viome Life Sciences has secured $86.5 million in Series C funding. This substantial funding ...
© 2023 ustechtimes.com